Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Beloranib hemioxalate
Cat. No.:
OB0425LY-166
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Beloranib hemioxalate is a potent fumagillin-class methionine aminopetidase-2 (MetAP2) inhibitor that effectively inhibits pathways associated with fat metabolism.
Synonyms:
529511-79-3; ZGN-440 Hemioxalate; ZGN-433 Hemioxalate; CDK732 Hemioxalate
CAS No.:
529511-79-3
Compound CID:
25144864
Formula:
C29H41NO6.1/2C2H2O4
Formula Weight:
1089.32
Specification
Target:
MetAP
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
Beloranib hemioxalate is mainly used in the study of obesity and metabolic abnormalities associated with obesity, such as type 2 diabetes. It works by regulating energy balance and reducing lipogenesis.
